New bone graft aims to cut repeat surgeries in spine deformity patients

NCT ID NCT05038527

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared a new bone graft material (ABM/P-15) to the standard bone graft in 120 adults having surgery for spinal deformity. The goal was to see if the new graft leads to fewer additional surgeries and better bone healing. Patients were randomly assigned to receive either the new or standard graft, and results were tracked over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ABM/P-15 bone graft (anorganic bovine bone mineral coated with a bioactive peptide)

What this could lead to

If it works, this could mean fewer repeat surgeries and faster bone healing for adults undergoing spinal deformity surgery.

What could go wrong

This is a single, completed trial with 120 patients, so results may not apply to everyone. The new graft might not be better than the standard approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINE DEFORMITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vertebral column disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rigshospitalet, Department of Orthopedics, Spine Unit

    Copenhagen, Denmark